YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells
Yuchen Bai(The University of Melbourne), Charbel Darido(The University of Melbourne)
Cited by 37
Related Papers
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
|Cancer Cell|2015|518
BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models
|PLoS ONE|2013|205
Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer
|Oncotarget|2013|179
mTOR Signalling in Head and Neck Cancer: Heads Up
|Cells|2019|68
A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation
|Molecular Cancer Therapeutics|2014|46